世界の前臨床CRO市場2021-2028:サービス別(毒性試験、バイオアナリシス、DMPK研究)、最終用途別(バイオ製薬会社、政府・学術機関)

◆英語タイトル:Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End-use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC060
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:240
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の前臨床CRO市場規模が2028年までに84憶ドルに達すると予測しています。2021年から2028年までに年平均8.1%成長する見通しです。本調査レポートでは、前臨床CROの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、サービス別(バイオアナリシス・DMPK研究、毒性試験、その他)分析、最終用途別(バイオ製薬会社、政府・学術機関、医療機器会社)分析、地域別分析、競争分析などを掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・前臨床CROの世界市場規模:サービス別(バイオアナリシス・DMPK研究、毒性試験、その他)
・前臨床CROの世界市場規模:最終用途別(バイオ製薬会社、政府・学術機関、医療機器会社)
・前臨床CROの世界市場規模:地域別
・競争分析
【レポートの概要】

Preclinical CRO Market Growth & Trends

The global preclinical CRO market size is expected to reach USD 8.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.1% from 2021 to 2028. The market is expected to witness lucrative growth over the forecast period due to increasing R&D expenditure and growing outsourcing trend. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the market growth over the forecast period.

The market is undergoing a series of mergers and acquisitions, resulting in the improvement in full-service capabilities and international reach of larger companies. For instance, in 2019, WuXi AppTec acquired Pharmapace. On the other hand, mid-sized and smaller contract research organizations (CROs) are focusing on niche sectors and are providing a personalized approach to their sponsors. Various companies are focusing on research and development of new drugs, and therefore are outsourcing these activities to launch efficient CRO services in the market. This, in turn, provides a positive atmosphere for joint ventures among market participants owing to the preference of sponsors to maximize their benefits.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 20, 2021, more than 96.7 million cases of COVID-19 were reported globally, with more than 2,068,303 deaths across the globe. This pandemic has fast-tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in preclinical studies as well as trials.

North America held the largest share of 47.7% in 2020. Significant investment in healthcare R&D, coupled with well-developed healthcare infrastructure in the U.S., is contributing to the largest share of North America. Asia Pacific is projected to expand at the fastest CAGR of 12.0% over the forecast period.

Preclinical CRO Market Report Highlights

• By service, the toxicology testing segment accounted for the largest share of 61.1% in 2020 due to its significance in Investigational New Drug (IND)-enabling studies

• Based on end-use, the government and academic institutes segment is anticipated to register the highest CAGR of 8.4% over the forecast period due to improving government initiatives toward healthcare, especially in developing economies

• North America dominated the market in 2020 with a share of 47.7%. Significant healthcare expenditure on R&D is one of the major factors driving the market in this region

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and end-use scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Preclinical CRO Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Surging number of drugs in preclinical phases
3.4.1.2. Economies of production and scale
3.4.1.3. Increasing R&D expenditure
3.4.2. Market Restraint Analysis
3.4.2.1. High labor cost
3.4.2.2. Stringent regulatory policies
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. Preclinical CRO: Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Preclinical CRO Market: Segment Analysis, by Service, 2016 – 2028 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2020 & 2028
4.3. Segment Dashboard
4.4. Global Preclinical CRO Market, by service, 2016 to 2028
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Bioanalysis and DMPK studies
4.5.2. Toxicology testing
4.5.3. Others
Chapter 5. Preclinical CRO Market: Segment Analysis, By End Use, 2016 – 2028 (USD Million)
5.1. Definitions & Scope
5.2. End-use market share analysis, 2020 & 2028
5.3. Segment Dashboard
5.4. Global Preclinical CRO market, by end use, 2016 to 2028
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Biopharmaceutical companies
5.5.2. Government and academic institutes
5.5.3. Medical device companies
Chapter 6. Preclinical CRO Market: Regional Market Analysis, By Service, End Use, 2016 – 2028 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2020 & 2028
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2028:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 – 2028 (USD Million)
6.7.2. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.7.3. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.7.4.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.7.5.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 – 2028 (USD Million)
6.8.2. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.3. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8.4. Germany
6.8.4.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.4.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8.5. U.K.
6.8.5.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.5.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.6.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.7.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.8.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8.9. Netherlands
6.8.9.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.9.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8.10. Belgium
6.8.10.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.10.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8.11. Switzerland
6.8.11.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.11.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8.12. Russia
6.8.12.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.12.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.8.13. Sweden
6.8.13.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.8.13.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 – 2028 (USD Million)
6.9.2. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.3. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9.4. China
6.9.4.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.4.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9.5. Japan
6.9.5.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.5.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.6.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9.7. Australia
6.9.7.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.7.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.8.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9.9. Malaysia
6.9.9.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.9.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9.10. Indonesia
6.9.11. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.12. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9.13. Singapore
6.9.14. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.15. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9.16. Philippines
6.9.17. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.18. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.9.19. Thailand
6.9.20. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.9.21. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, by country, 2016 – 2028 (USD Million)
6.10.2. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.10.3. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.10.4. Brazil
6.10.4.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.10.4.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.10.5. Mexico
6.10.5.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.10.5.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.10.6. Argentina
6.10.6.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.10.6.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.10.7. Colombia
6.10.7.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.10.7.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.10.8. Chile
6.10.8.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.10.8.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.11. Middle East and Africa
6.11.1. Market estimates and forecast, by country, 2016 – 2028 (USD Million)
6.11.2. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.11.3. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.11.4. South Africa
6.11.4.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.11.4.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.11.5. Saudi Arabia
6.11.5.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.11.5.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.11.6. UAE
6.11.6.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.11.6.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.11.7. Israel
6.11.7.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.11.7.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
6.11.8. Egypt
6.11.8.1. Market estimates and forecast, by Service, 2016 – 2028 (USD Million)
6.11.8.2. Market estimates and forecast, by End Use, 2016 – 2028 (USD Million)
Chapter 7. Preclinical CRO Market – Competitive Analysis
7.1. Key companies profiled
7.1.1. Envigo Corporation
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. MPI research
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Eurofins Scientific
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. PRA Health Sciences, Inc
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Wuxi AppTec
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Medpace, Inc.
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Pharmaceutical Product Development (PPD), LLC
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. PARAXEL International Corporation
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. ICON Plc.
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Laboratory Corporation of America, Inc.
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives 

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Preclinical CRO Market, By Region, 2016 - 2028 (USD Million)
Table 4 Global Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 5 Global Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 6 North America Preclinical CRO Market, By Country, 2016 - 2028 (USD Million)
Table 7 North America Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 8 North America Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 9 U.S. Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 10 U.S. Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 11 Canada Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 12 Canada Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 13 Europe Preclinical CRO Market, By Country, 2016 - 2028 (USD Million)
Table 14 Europe Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 15 Europe Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 16 U.K. Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 17 U.K. Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 18 Germany Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 19 Germany Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 20 France Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 21 France Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 22 Italy Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 23 Italy Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 24 Spain Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 25 Spain Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 26 Netherlands Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 27 Netherlands Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 28 Belgium Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 29 Belgium Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 30 Switzerland Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 31 Switzerland Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 32 Russia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 33 Russia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 34 Sweden Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 35 Sweden Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 36 Asia Pacific Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 37 Asia Pacific Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 38 China Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 39 China Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 40 Japan Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 41 Japan Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 42 India Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 43 India Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 44 Australia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 45 Australia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 46 South Korea Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 47 South Korea Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 48 Malaysia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 49 Malaysia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 50 Indonesia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 51 Indonesia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 52 Singapore Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 53 Singapore Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 54 Philippines Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 55 Philippines Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 56 Thailand Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 57 Thailand Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 58 Latin America Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 59 Latin America Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 60 Brazil Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 61 Brazil Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 62 Mexico Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 63 Mexico Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 64 Argentina Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 65 Argentina Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 66 Colombia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 67 Colombia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 68 Chile Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 69 Chile Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 70 Middle East & Africa Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 71 Middle East & Africa Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 72 South Africa Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 73 South Africa Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 74 Saudi Arabia Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 75 Saudi Arabia Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 76 UAE Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 77 UAE Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 78 Israel Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 79 Israel Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million)
Table 80 Egypt Preclinical CRO Market, By Service, 2016 - 2028 (USD Million)
Table 81 Egypt Preclinical CRO Market, By End Use, 2016 - 2028 (USD Million) 


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Preclinical CRO Market: Market snapshot
Fig. 9 Preclinical CRO Market: Market segmentation
Fig. 10 Preclinical CRO Market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Preclinical CRO Market driver impact
Fig. 14 Preclinical CRO Market restraint impact
Fig. 15 Preclinical CRO Market porter’s five forces analysis
Fig. 16 Preclinical CRO Market PESTEL analysis
Fig. 17 Preclinical CRO Market segment dashboard
Fig. 18 Preclinical CRO Market: Service movement Analysis
Fig. 19 Bioanalysis and DMPK studies market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 20 Toxicology testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 21 Others market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 22 Preclinical CRO Market segment dashboard
Fig. 23 Preclinical CRO Market: End-use Movement Analysis
Fig. 24 Biopharmaceutical companies market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 25 Government and academic institutes market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 26 Medical device companies market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 27 Global Preclinical CRO Market: Regional movement analysis
Fig. 28 Global Preclinical CRO Market: Regional Outlook and key takeaways
Fig. 29 Global market share, by region
Fig. 30 North America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 31 U.S. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 32 Canada market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 33 Europe market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 34 U.K. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 35 Germany market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 36 France market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 37 Italy market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 38 Spain market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 39 Netherlands market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 40 Belgium market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 41 Switzerland market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 42 Russia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 43 Sweden market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 44 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 45 China market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 46 Japan market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 47 India market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 48 Australia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 49 South Korea market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 50 Malaysia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 51 Indonesia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 52 Singapore market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 53 Philippines market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 54 Thailand market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 55 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 56 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 57 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 58 Argentina market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 59 Colombia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 60 Chile market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 61 Middle East and Africa. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 62 South Africa market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 63 Saudi Arabia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 64 UAE market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 65 Israel market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 66 Egypt market estimates and forecast, 2016 - 2028 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の前臨床CRO市場2021-2028:サービス別(毒性試験、バイオアナリシス、DMPK研究)、最終用途別(バイオ製薬会社、政府・学術機関)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆